El Centro de Estudios Biosanitarios refuerza su compromiso con la formación de excelencia y la investigación en cáncer a través de la firma de diversos convenios de colaboración con entidades del...
Read moreSponsored by F. Hoffmann-La Roche Ltd, in collaboration with Vall d’Hebron Institute of Oncology (VHIO), a first-in-human clinical trial was designed to assess the safety, maximum tolerated dose, an...
Read moreThe results suggest that increasing aerobic activity may provide protection against various cardiovascular, inflammatory, and other diseases.
Read moreHan demostrado que la activación de la proteína receptor sigma-1 mejora el funcionamiento del corazón y de los vasos sanguíneos del pulmón en un modelo animal de hipertensión arterial pulmonar.
Read moreThe study reveals that 70% of the cellular response to metabolic stress is regulated at the translation of messenger RNA—a level of control that redefines how we interpret the gene expression reprog...
Read moreLa Dra. Marta Alonso lidera el proyecto de un nuevo virus oncolítico contra los gliomas de línea media difusa y el Dr. Iñaki Eguren investigará en el Reino Unido la respuesta del carcinoma renal a...
Read moreEl Dr. Antoni Torres Coll ha desarrollado en su tesis doctoral en IQS un sistema de nanomedicina basada en polímeros para la administración inhalada de ARN terapéutico para el cáncer de pulmón, i...
Read moreUn estudio en ratones del CSIC describe un ‘puente’ de neuronas entre los hemisferios del hipocampo, esencial para la orientación espacial y la toma de decisiones basadas en la memoria
Read moreScientist at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) and the Institute for Research in Biomedicine (IRB Barcelona) uncover a key metabolic mechanism governing immune ...
Read moreKidney dysfunction disrupts lipid metabolism and accelerates atherosclerosis
Read more20% of breast cancer diagnoses are actually precancerous lesions. As it is not yet possible to know which ones will progress to cancer, the vast majority are treated as if they were already cancerous
Read moreAfter more than a decade of research, a new-generation CAR-T therapy developed by VHIO, in collaboration with the Hospital del Mar Research Institute, has been administered to patients for the first t...
Read more